|
Mibc-pharma
|
About Us
We are working to build a vibrant, growing cancer company. We aspire to become a leading discoverer and developer of small-molecule drugs to treat patients in the greatest areas of medical need. Equally important: to be known for the highest standards of integrity and stewardship in serving patients, the medical community, employees and shareholders.This is the MIBC we see. Below are highlights of our strategy to make that vision a reality:
Attract, develop and retain the best and brightest minds_build upon our solid team of people, seeking individuals from diverse backgrounds in drug discovery and development, manufacturing, financial management and business strategy.
Leverage MIBC's unique strengths_scientific excellence and clinical scholarship_to broadly develop our lead oncology product candidates and build a pipeline of innovative follow-on product candidates.
Enter into partnerships with major pharmaceutical or biotechnology companies to accelerate development of our cancer product candidates and commercialize them in selected markets.
Company Profile
| Annual Sales Amount: | Above US$100 Million |
| Total No. of Staff: | Above 1000 People |
| No. of R&D Staff: | Above 100 People |
| No. of Engineers: | Above 100 People |
| Export Ratio: | 71% – 80% |
| OEM Services Provided: | NO |
| Payment Terms: | L/C |
| Business Type: | Manufacturer, Distributor/Wholesaler |
| Quality Certificate: | ISO14001, FDA |
| Main Export Markets: | Western Europe, Eastern Europe, Southeast Asia, Mid East, Africa |
